MY8-27361-55390
3 vaccinations
2 coded responses
3 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 272 / NC
- Registered
- 2022-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2022-01-05
Registered in v-safe
-
2022-01-05
Dose 3 — Pfizer-BioNTech
-
2022-01-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-01-07
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Lymph node swollen under arm of injection.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain — Feeling: Good · Site: PainFree text: Pain in my lymph node under my arm.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | No |
| 2 | 2021-01-05 | Pfizer-BioNTech | No |
| 3 | 2022-01-05 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph node swollen under arm of injection.
Systemic reaction (other): Pain in my lymph node under my arm.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release